Brain Imaging and Retreatment Study of Persistent Lyme Disease

NCT00037479 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

NIH

Sponsor class

Conditions

Lyme Disease
Lyme Neuroborreliosis

Interventions

DRUG: ceftriaxone

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)